Published on 25 Jan 2023 on Zacks via Yahoo Finance

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen Corporation ABC is well-poised for growth on the back of its robust U.S. Healthcare Solutions business and product launches. Intense competition, though, remains a concern.

Shares of this currently Zacks Rank #3 (Hold) player have gained 12% compared with the industry’s increase of 4.7% in the past six months. The S&P 500 Index has increased 0.7% in the same time frame.

With a market capitalization of $33.26 billion, AmerisourceBergen is one of the world’s largest pharmaceutical services companies, focused on providing drug distribution and related services to reduce healthcare costs and improve patient outcomes. The company’s earnings are anticipated to improve 8.6% over the next five years. It beat earnings estimates in three of the trailing four quarters and missed the mark once, the average surprise being 2.51%.